A Phase 3, Randomized Study of Zanubrutinib (BGB-3111) Compared with Ibrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC 206/18 (ERM Project ID 45010)
NMA SSA Reference Number: SSA/45010/MonH-2019-171072(v1)
Monash Health Ref: RES-19-0000-299X
StatusFinished
Effective start/end date20/05/19 → 19/05/24

Keywords

  • clinical trial
  • leukemia
  • treatment efficacy